Response to the letter to the editor: 'Olezarsen, a liver-directed ASO therapy for hypertriglyceridemia'.

Expert Opin Pharmacother

Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital & Fiona Stanley Hospital Network, Perth Western Australia, Australia.

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2024.2437524DOI Listing

Publication Analysis

Top Keywords

response letter
4
letter editor
4
editor 'olezarsen
4
'olezarsen liver-directed
4
liver-directed aso
4
aso therapy
4
therapy hypertriglyceridemia'
4
response
1
editor
1
'olezarsen
1

Similar Publications

Cardiovascular diseases (CVDs) continue to be a substantial global healthcare burden despite considerable progress in therapies. The inflammatory response during the progression of CVD has attracted considerable attention. Mitochondria serve as the principal energy source for the heart.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!